Clinical Nutrition Market - Global Clinical Nutrition Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 -

Description

The global clinical nutrition market, valued at approximately US$35 billion, is poised for significant expansion, expected to exceed US$70 billion by 2030.

Market revenue is projected to grow robustly at a CAGR of 8% during the period from 2023 to 2030.

Key Trends Driving Market Growth

Advancements in Clinical Nutrition Science: The market is being driven by developments in clinical nutrition science. Nutritional genomics and personalized medicine now enable customized clinical nutrition protocols tailored to individual genetic profiles and dietary requirements, making interventions more effective.

Rising Incidence of Malnutrition: The increasing prevalence of malnutrition, often affecting hospitalized individuals due to diseases, surgeries, or inability to consume regular meals, is a significant growth driver for clinical nutrition. It plays a crucial role in meeting the nutritional needs of patients and aiding in their recovery.

Lack of Consumer and Healthcare Professional Knowledge: The market's growth potential may be hindered by a lack of awareness about the benefits of clinical nutrition among consumers and healthcare professionals. Better education and training are required to promote the proper use of therapeutic nutrition products.

Category Dominance and Growth Prospects

Oral Category Dominance: In 2022, the oral category dominated the industry. Nutritional bars, providing a concentrated source of calories, protein, and nutrients, are practical for on-the-go nutrition and are widely used by athletes, people with higher calorie requirements, or those in need of an immediate nutritional boost.

Neurological Disorders Category: The neurological disorders category dominated the industry in 2022. Customized nutrition plans are often necessary for individuals undergoing neurological rehabilitation, such as traumatic brain injury (TBI) or spinal cord injury (SCI).

Growing Adult Category: The adult category is expected to experience significant growth during the forecast period, supporting the health and development of pregnant and nursing women, as well as ensuring appropriate nutrient intake during different life stages.

Regional Market Outlook

North America Dominance: North America is expected to dominate the clinical nutrition market during the forecast period, driven by the adoption of telehealth and digital health solutions, including tele-nutrition services, making clinical nutrition services more accessible.

Asia Pacific's Fastest Growth: Asia Pacific is expected to be the fastest-growing clinical nutrition market region, with international and regional businesses offering innovative products tailored to the nutritional and cultural demands of the Asian population.

Key Growth Determinants

Rising Prevalence of Chronic Diseases: The increasing prevalence of chronic diseases has led to a higher demand for specialized nutritional support, with clinical nutrition products playing a crucial role in maintaining the health and improving outcomes of patients with different chronic illnesses.

Increasing Demand for Nutritional Therapy: Growing awareness of the importance of nutrition in maintaining overall health and treating diseases has led to a higher demand for personalized dietary counseling and therapies, creating opportunities for specialized therapeutic nutrition solutions.

Growing Healthcare Expenditure: As healthcare spending rises, healthcare organizations allocate more funds to patient care, including clinical nutrition treatment and products, enhancing the availability of clinical nutrition services.

Key Trends and Opportunities

Rising Plant-based Clinical Nutrition: Increased consumer demand for plant-based clinical nutrition products is driven by awareness of the health benefits of plant-based diets, offering opportunities for plant-based clinical nutrition products catering to dietary preferences and allergies.

Increasing Adoption of Telehealth: Telehealth platforms are making clinical nutrition consultations and guidance more accessible, particularly in underprivileged or remote areas, improving patient involvement in healthcare and real-time monitoring of nutrition programs.

Growing Nutritional Support in Critical Care: Critical care patients have specialized nutritional needs, and clinical nutrition support can improve patient outcomes, creating opportunities in this segment.

Competitive Landscape

The global clinical nutrition market is consolidated, with a few well-known companies as competitors. These companies are introducing new products and expanding distribution systems to gain market share. Further consolidation is expected in the coming years.

Key Market Leaders

Perrigo Company Plc

Hero Nutritionals Inc.

Abbott Laboratories

Danone Nutricia

B. Braun

Baxter International Inc.

Fresenius SE & Co. KGaA

Pfizer Inc.

Lonza Ltd.

Nestle S.A.

Meiji Holdings Co., Ltd.

Mead Johnson Nutrition

Vivify Health

Ketogenic

FMC Corporation.

1. Executive Summary

1.1. Global Clinical Nutrition Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2022
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Clinical Nutrition Market Outlook, 2018 - 2030

3.1. Global Clinical Nutrition Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2030
- 3.1.1. Key Highlights
  - 3.1.1.1. Oral
  - 3.1.1.2. Enteral
  - 3.1.1.3. Parental
3.2. Global Clinical Nutrition Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
- 3.2.1. Key Highlights
  - 3.2.1.1. Cancer
  - 3.2.1.2. Metabolic Disorders
  - 3.2.1.3. Gastrointestinal Disorders
  - 3.2.1.4. Neurological Disorders
  - 3.2.1.5. Malnutrition
  - 3.2.1.6. Others
3.3. Global Clinical Nutrition Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
- 3.3.1. Key Highlights
  - 3.3.1.1. Pediatric
  - 3.3.1.2. Adult
  - 3.3.1.3. Geriatric
3.4. Global Clinical Nutrition Market Outlook, by Region, Value (US$ Bn), 2018 - 2030
- 3.4.1. Key Highlights
  - 3.4.1.1. North America
  - 3.4.1.2. Europe
  - 3.4.1.3. Asia Pacific
  - 3.4.1.4. Latin America
  - 3.4.1.5. Middle East & Africa

4. North America Clinical Nutrition Market Outlook, 2018 - 2030

4.1. North America Clinical Nutrition Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2030
- 4.1.1. Key Highlights
  - 4.1.1.1. Oral
  - 4.1.1.2. Enteral
  - 4.1.1.3. Parental
4.2. North America Clinical Nutrition Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
- 4.2.1. Key Highlights
  - 4.2.1.1. Cancer
  - 4.2.1.2. Metabolic Disorders
  - 4.2.1.3. Gastrointestinal Disorders
  - 4.2.1.4. Neurological Disorders
  - 4.2.1.5. Malnutrition
  - 4.2.1.6. Others
4.3. North America Clinical Nutrition Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
- 4.3.1. Key Highlights
  - 4.3.1.1. Pediatric
  - 4.3.1.2. Adult
  - 4.3.1.3. Geriatric
- 4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Clinical Nutrition Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
- 4.4.1. Key Highlights
  - 4.4.1.1. U.S. Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2018 - 2030
  - 4.4.1.2. U.S. Clinical Nutrition Market, by Application, Value (US$ Bn), 2018 - 2030
  - 4.4.1.3. U.S. Clinical Nutrition Market, by End user, Value (US$ Bn), 2018 - 2030
  - 4.4.1.4. Canada Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2018 - 2030
  - 4.4.1.5. Canada Clinical Nutrition Market, by Application, Value (US$ Bn), 2018 - 2030
  - 4.4.1.6. Canada Clinical Nutrition Market, by End user, Value (US$ Bn), 2018 - 2030
- 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Clinical Nutrition Market Outlook, 2018 - 2030

5.1. Europe Clinical Nutrition Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2030
- 5.1.1. Key Highlights
  - 5.1.1.1. Oral
  - 5.1.1.2. Enteral
  - 5.1.1.3. Parental
5.2. Europe Clinical Nutrition Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
- 5.2.1. Key Highlights
  - 5.2.1.1. Cancer
  - 5.2.1.2. Metabolic Disorders
  - 5.2.1.3. Gastrointestinal Disorders
  - 5.2.1.4. Neurological Disorders
  - 5.2.1.5. Malnutrition
  - 5.2.1.6. Others
5.3. Europe Clinical Nutrition Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
- 5.3.1. Key Highlights
  - 5.3.1.1. Pediatric
  - 5.3.1.2. Adult
  - 5.3.1.3. Geriatric
- 5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Clinical Nutrition Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
- 5.4.1. Key Highlights
  - 5.4.1.1. Germany Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2018 - 2030
  - 5.4.1.2. Germany Clinical Nutrition Market, by Application, Value (US$ Bn), 2018 - 2030
  - 5.4.1.3. Germany Clinical Nutrition Market, by End user, Value (US$ Bn), 2018 - 2030
  - 5.4.1.4. U.K. Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2018 - 2030
  - 5.4.1.5. U.K. Clinical Nutrition Market, by Application, Value (US$ Bn), 2018 - 2030
  - 5.4.1.6. U.K. Clinical Nutrition Market, by End user, Value (US$ Bn), 2018 - 2030
  - 5.4.1.7. France Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2018 - 2030
  - 5.4.1.8. France Clinical Nutrition Market, by Application, Value (US$ Bn), 2018 - 2030
  - 5.4.1.9. France Clinical Nutrition Market, by End user, Value (US$ Bn), 2018 - 2030
  - 5.4.1.10. Italy Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2018 - 2030
  - 5.4.1.11. Italy Clinical Nutrition Market, by Application, Value (US$ Bn), 2018 - 2030
  - 5.4.1.12. Italy Clinical Nutrition Market, by End user, Value (US$ Bn), 2018 - 2030
  - 5.4.1.13. Turkey Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2018 - 2030
  - 5.4.1.14. Turkey Clinical Nutrition Market, by Application, Value (US$ Bn), 2018 - 2030
  - 5.4.1.15. Turkey Clinical Nutrition Market, by End user, Value (US$ Bn), 2018 - 2030
  - 5.4.1.16. Russia Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2018 - 2030
  - 5.4.1.17. Russia Clinical Nutrition Market, by Application, Value (US$ Bn), 2018 - 2030
  - 5.4.1.18. Russia Clinical Nutrition Market, by End user, Value (US$ Bn), 2018 - 2030
  - 5.4.1.19. Rest of Europe Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2018 - 2030
  - 5.4.1.20. Rest of Europe Clinical Nutrition Market, by Application, Value (US$ Bn), 2018 - 2030
  - 5.4.1.21. Rest of Europe Clinical Nutrition Market, by End user, Value (US$ Bn), 2018 - 2030
- 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Clinical Nutrition Market Outlook, 2018 - 2030

6.1. Asia Pacific Clinical Nutrition Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2030
- 6.1.1. Key Highlights
  - 6.1.1.1. Oral
  - 6.1.1.2. Enteral
  - 6.1.1.3. Parental
6.2. Asia Pacific Clinical Nutrition Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
- 6.2.1. Key Highlights
  - 6.2.1.1. Cancer
  - 6.2.1.2. Metabolic Disorders
  - 6.2.1.3. Gastrointestinal Disorders
  - 6.2.1.4. Neurological Disorders
  - 6.2.1.5. Malnutrition
  - 6.2.1.6. Others
6.3. Asia Pacific Clinical Nutrition Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
- 6.3.1. Key Highlights
  - 6.3.1.1. Pediatric
  - 6.3.1.2. Adult
  - 6.3.1.3. Geriatric
- 6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Clinical Nutrition Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
- 6.4.1. Key Highlights
  - 6.4.1.1. China Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2018 - 2030
  - 6.4.1.2. China Clinical Nutrition Market, by Application, Value (US$ Bn), 2018 - 2030
  - 6.4.1.3. China Clinical Nutrition Market, by End user, Value (US$ Bn), 2018 - 2030
  - 6.4.1.4. Japan Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2018 - 2030
  - 6.4.1.5. Japan Clinical Nutrition Market, by Application, Value (US$ Bn), 2018 - 2030
  - 6.4.1.6. Japan Clinical Nutrition Market, by End user, Value (US$ Bn), 2018 - 2030
  - 6.4.1.7. South Korea Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2018 - 2030
  - 6.4.1.8. South Korea Clinical Nutrition Market, by Application, Value (US$ Bn), 2018 - 2030
  - 6.4.1.9. South Korea Clinical Nutrition Market, by End user, Value (US$ Bn), 2018 - 2030
  - 6.4.1.10. India Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2018 - 2030
  - 6.4.1.11. India Clinical Nutrition Market, by Application, Value (US$ Bn), 2018 - 2030
  - 6.4.1.12. India Clinical Nutrition Market, by End user, Value (US$ Bn), 2018 - 2030
  - 6.4.1.13. Southeast Asia Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2018 - 2030
  - 6.4.1.14. Southeast Asia Clinical Nutrition Market, by Application, Value (US$ Bn), 2018 - 2030
  - 6.4.1.15. Southeast Asia Clinical Nutrition Market, by End user, Value (US$ Bn), 2018 - 2030
  - 6.4.1.16. Rest of Asia Pacific Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2018 - 2030
  - 6.4.1.17. Rest of Asia Pacific Clinical Nutrition Market, by Application, Value (US$ Bn), 2018 - 2030
  - 6.4.1.18. Rest of Asia Pacific Clinical Nutrition Market, by End user, Value (US$ Bn), 2018 - 2030
- 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Clinical Nutrition Market Outlook, 2018 - 2030

7.1. Latin America Clinical Nutrition Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2030
- 7.1.1. Key Highlights
  - 7.1.1.1. Oral
  - 7.1.1.2. Enteral
  - 7.1.1.3. Parental
7.2. Latin America Clinical Nutrition Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
- 7.2.1. Key Highlights
  - 7.2.1.1. Cancer
  - 7.2.1.2. Metabolic Disorders
  - 7.2.1.3. Gastrointestinal Disorders
  - 7.2.1.4. Neurological Disorders
  - 7.2.1.5. Malnutrition
  - 7.2.1.6. Others
7.3. Latin America Clinical Nutrition Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
- 7.3.1. Key Highlights
  - 7.3.1.1. Pediatric
  - 7.3.1.2. Adult
  - 7.3.1.3. Geriatric
- 7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Clinical Nutrition Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
- 7.4.1. Key Highlights
  - 7.4.1.1. Brazil Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2018 - 2030
  - 7.4.1.2. Brazil Clinical Nutrition Market, by Application, Value (US$ Bn), 2018 - 2030
  - 7.4.1.3. Brazil Clinical Nutrition Market, by End user, Value (US$ Bn), 2018 - 2030
  - 7.4.1.4. Mexico Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2018 - 2030
  - 7.4.1.5. Mexico Clinical Nutrition Market, by Application, Value (US$ Bn), 2018 - 2030
  - 7.4.1.6. Mexico Clinical Nutrition Market, by End user, Value (US$ Bn), 2018 - 2030
  - 7.4.1.7. Argentina Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2018 - 2030
  - 7.4.1.8. Argentina Clinical Nutrition Market, by Application, Value (US$ Bn), 2018 - 2030
  - 7.4.1.9. Argentina Clinical Nutrition Market, by End user, Value (US$ Bn), 2018 - 2030
  - 7.4.1.10. Rest of Latin America Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2018 - 2030
  - 7.4.1.11. Rest of Latin America Clinical Nutrition Market, by Application, Value (US$ Bn), 2018 - 2030
  - 7.4.1.12. Rest of Latin America Clinical Nutrition Market, by End user, Value (US$ Bn), 2018 - 2030
- 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Clinical Nutrition Market Outlook, 2018 - 2030

8.1. Middle East & Africa Clinical Nutrition Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2030
- 8.1.1. Key Highlights
  - 8.1.1.1. Oral
  - 8.1.1.2. Enteral
  - 8.1.1.3. Parental
8.2. Middle East & Africa Clinical Nutrition Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
- 8.2.1. Key Highlights
  - 8.2.1.1. Cancer
  - 8.2.1.2. Metabolic Disorders
  - 8.2.1.3. Gastrointestinal Disorders
  - 8.2.1.4. Neurological Disorders
  - 8.2.1.5. Malnutrition
  - 8.2.1.6. Others
8.3. Middle East & Africa Clinical Nutrition Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
- 8.3.1. Key Highlights
  - 8.3.1.1. Pediatric
  - 8.3.1.2. Adult
  - 8.3.1.3. Geriatric
- 8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Clinical Nutrition Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
- 8.4.1. Key Highlights
  - 8.4.1.1. GCC Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2018 - 2030
  - 8.4.1.2. GCC Clinical Nutrition Market, by Application, Value (US$ Bn), 2018 - 2030
  - 8.4.1.3. GCC Clinical Nutrition Market, by End user, Value (US$ Bn), 2018 - 2030
  - 8.4.1.4. South Africa Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2018 - 2030
  - 8.4.1.5. South Africa Clinical Nutrition Market, by Application, Value (US$ Bn), 2018 - 2030
  - 8.4.1.6. South Africa Clinical Nutrition Market, by End user, Value (US$ Bn), 2018 - 2030
  - 8.4.1.7. Egypt Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2018 - 2030
  - 8.4.1.8. Egypt Clinical Nutrition Market, by Application, Value (US$ Bn), 2018 - 2030
  - 8.4.1.9. Egypt Clinical Nutrition Market, by End user, Value (US$ Bn), 2018 - 2030
  - 8.4.1.10. Nigeria Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2018 - 2030
  - 8.4.1.11. Nigeria Clinical Nutrition Market, by Application, Value (US$ Bn), 2018 - 2030
  - 8.4.1.12. Nigeria Clinical Nutrition Market, by End user, Value (US$ Bn), 2018 - 2030
  - 8.4.1.13. Rest of Middle East & Africa Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2018 - 2030
  - 8.4.1.14. Rest of Middle East & Africa Clinical Nutrition Market, by Application, Value (US$ Bn), 2018 - 2030
  - 8.4.1.15. Rest of Middle East & Africa Clinical Nutrition Market, by End user, Value (US$ Bn), 2018 - 2030
- 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Manufacturer vs Application Heatmap
9.2. Company Market Share Analysis, 2022
9.3. Competitive Dashboard
9.4. Company Profiles
- 9.4.1. Hero Nutritionals Inc.
  - 9.4.1.1. Company Overview
  - 9.4.1.2. Product Portfolio
  - 9.4.1.3. Financial Overview
  - 9.4.1.4. Business Strategies and Development
- 9.4.2. Abbott Laboratories
  - 9.4.2.1. Company Overview
  - 9.4.2.2. Product Portfolio
  - 9.4.2.3. Financial Overview
  - 9.4.2.4. Business Strategies and Development
- 9.4.3. Danone Nutricia
  - 9.4.3.1. Company Overview
  - 9.4.3.2. Product Portfolio
  - 9.4.3.3. Financial Overview
  - 9.4.3.4. Business Strategies and Development
- 9.4.4. B. Braun Melsungen Ag
  - 9.4.4.1. Company Overview
  - 9.4.4.2. Product Portfolio
  - 9.4.4.3. Financial Overview
  - 9.4.4.4. Business Strategies and Development
- 9.4.5. Baxter International Inc.
  - 9.4.5.1. Company Overview
  - 9.4.5.2. Product Portfolio
  - 9.4.5.3. Financial Overview
  - 9.4.5.4. Business Strategies and Development
- 9.4.6. Fresenius Se & Co. Kgaa
  - 9.4.6.1. Company Overview
  - 9.4.6.2. Product Portfolio
  - 9.4.6.3. Financial Overview
  - 9.4.6.4. Business Strategies and Development
- 9.4.7. Pfizer Inc.
  - 9.4.7.1. Company Overview
  - 9.4.7.2. Product Portfolio
  - 9.4.7.3. Financial Overview
  - 9.4.7.4. Business Strategies and Development
- 9.4.8. Lonza Ltd.
  - 9.4.8.1. Company Overview
  - 9.4.8.2. Product Portfolio
  - 9.4.8.3. Financial Overview
  - 9.4.8.4. Business Strategies and Development
- 9.4.9. Nestle S.A.
  - 9.4.9.1. Company Overview
  - 9.4.9.2. Product Portfolio
  - 9.4.9.3. Financial Overview
  - 9.4.9.4. Business Strategies and Development
- 9.4.10. Meiji Holdings Co., Ltd.
  - 9.4.10.1. Company Overview
  - 9.4.10.2. Product Portfolio
  - 9.4.10.3. Financial Overview
  - 9.4.10.4. Business Strategies and Development
- 9.4.11. Mead Johnson Nutrition
  - 9.4.11.1. Company Overview
  - 9.4.11.2. Product Portfolio
  - 9.4.11.3. Financial Overview
  - 9.4.11.4. Business Strategies and Development
- 9.4.12. Vivify Health
  - 9.4.12.1. Company Overview
  - 9.4.12.2. Product Portfolio
  - 9.4.12.3. Financial Overview
  - 9.4.12.4. Business Strategies and Development
- 9.4.13. Ketogen
  - 9.4.13.1. Company Overview
  - 9.4.13.2. Product Portfolio
  - 9.4.13.3. Financial Overview
  - 9.4.13.4. Business Strategies and Development
- 9.4.14. FMC Corporation
  - 9.4.14.1. Company Overview
  - 9.4.14.2. Product Portfolio
  - 9.4.14.3. Financial Overview
  - 9.4.14.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations